Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Reminder: Invitation to Late-stage pipeline event, Tuesday, 1 October 2013 Dienstag, 24. September 2013 - 15:30

Basel, 24 September 2013
The Roche Investor Relations team would like to invite you to a Late-stage pipeline eventthat will take place in London on 1 October 2013 starting at 2.30pm local time.
The event will provide an opportunity to discuss clinical data and development plans for key late-stage compounds in the Roche development pipeline, including lampalizumab (anti-factor D) in dry AMD, etrolizumab in ulcerative colitis and selected oncology compounds.

Presenters:

Alan Hippe, Chief Financial and IT Officer - Introduction
Hal Barron, Head of Global Product Development, Chief Medical Officer - Pipeline update
Karl Mahler, Head of Investor Relations - Moderator

Up

 

Meeting information (download to my calendar)
Date: Time: 1 October 2013 2:00pm Registration 2:30pm Meeting start 4:00pm Meeting end, followed by drinks and canapés
Venue: The Haberdashers' Hall, 18 West Smithfield, London EC1A 9HQ, UK (map)
To register for the event please follow this link.
This presentation can be viewed through a live video webcast accessed via http://ir.roche.com.Alternatively, dial in to the conference 10-15 min prior to the scheduled start using the following numbers (listen-only mode, no live-access to speakers):
+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 203 059 5862 (UK)
+1 (1) 631 570 5613 (USA Toll Free)
A replay of the call will be available one hour after the conference call, for 48 hours. Access is by dialing:
+41 (0) 91 612 4330 (Europe and ROW)
+44 (0) 207 108 6233 (UK)
+1 (1) 866 416 2558 (USA)
and will be asked to enter the ID 13945 followed by the # sign.
A replay of the webcast will be available on demand at http://ir.roche.com.
Best regards,
Karl Mahler Head of Investor Relations Nina Mojas Investor Relations Officer

Up

Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com Luís Correia Ph.D. Phone: +41 61 68-75284 e-mail: luis.correia@roche.com
Dr. Nina Mojas Phone: +41 61 68-71300 e-mail: nina.mojas@roche.com Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Elhan Webb, CFA Phone: +41 61 68-89630 e-mail: elhan.webb@roche.com Tamer Farhan Ph.D. Phone: +41 61 68-82552 e-mail: tamer.farhan@roche.com
Thomas Kudsk Larsen Phone: +1 650 467-2016 e-mail: larsen.thomas@gene.com Nina Goworek Phone: +1 650 467-8737 e-mail: goworek.nina@gene.com
Ekaterine Kortkhonjia Ph.D. Phone: +1 650 467-5873 e-mail: kortkhonjia.ekaterine@gene.com
September 24 2013 Content owner:   Roche Investor Relations    ©2013 F. Hoffmann-La Roche Ltd.